Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02848859
Other study ID # 2014P000845
Secondary ID
Status Completed
Phase N/A
First received July 22, 2016
Last updated February 22, 2017
Start date March 2015
Est. completion date December 2016

Study information

Verified date February 2017
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a pilot study randomizing patients with insomnia and coronary heart disease to either general sleep hygiene counseling and web-based cognitive behavioral therapy for insomnia versus general sleep hygiene counseling alone (followed by the cognitive behavioral therapy at a later date).


Description:

For this pilot study, the investigators will recruit up to 30 participants with insomnia and coronary heart disease. Another 30 patients will be recruited from another institution. Patients will be screened with a modified version of the Insomnia Severity Index (ISI), a brief self-report instrument validated for identifying insomnia. The investigators will modify the ISI to include exclusionary criteria. The investigators will randomize participants to 6 weeks of access to web based cognitive behavioral therapy for insomnia (wCBT-I) using an internet based CBT-I program plus education provided through access to the Harvard Sleep Education web site (which provides general sleep education information only) compared to 6 weeks of access to the Harvard Sleep Education web site, followed by access to the web-CBT program (a wait list control group). The investigators will test the hypothesis that use of wCBT-I improves sleep quality and sleep duration as measured by sleep diaries and the ISI. A secondary goal of the study is to assess the recruitment yields, retention and adherence rates.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date December 2016
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- meet criteria for at least mild insomnia based on the Insomnia Severity Index questionnaire results

- have established coronary disease defined by: a) prior myocardial infarction or a coronary artery revascularization procedure; b) angiographically documented stenosis (>70%) of a major coronary artery; or c) prior ischemic stroke without major functional impairment.

- minimum age of 18 years old.

Exclusion Criteria:

- no daily access to a computer with an internet connection

- visual impairment preventing use of a computer

- inability to read English

- severe uncontrolled medical or psychiatric problems

- heart failure with reduced ejection fraction <35%

- high depressive symptoms (PHQ > 15)

- drowsy driving

- >3 days per week use of hypnotic medications

- known untreated sleep disordered breathing, narcolepsy, or restless leg syndrome

- shift-workers

- prior exposure to CBT-I treatment

- dialysis patient

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Go! to Sleep
This is an online interactive program that delivers cognitive behavioral therapy for insomnia via the internet.
General Sleep Education
Providing patients information on healthy sleep and habits to promote healthy sleep.

Locations

Country Name City State
United States Brigham and Womens Hospital Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Brigham and Women's Hospital The Cleveland Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline Insomnia Severity Index score at 6 weeks It is a 7 item, validated questionnaire to determine severity of insomnia symptoms. At baseline, at 6 weeks, and in the treatment arm at 12 weeks.
Secondary Change in sleep duration from baseline to 6 weeks The investigators will use sleep diaries that participants fill out for 1 week at baseline and at 6 weeks to compare sleep duration between arms as well as at 12 weeks in the treatment arm only to assess duration of treatment effect. At baseline, at 6 weeks, and in the treatment arm at 12 weeks.
Secondary Change in mood assessed using the Patient Health Questionnaire-8 from baseline to 6 weeks The investigators will use the Patient Health Questionnaire-8 to measure depressive symptoms At baseline, at 6 weeks, and in the treatment arm at 12 weeks.
Secondary Change in sleepiness assessed using the Epworth Sleepiness Questionnaire from baseline to 6 weeks The investigators will use the Epworth Sleepiness questionnaire to measure sleepiness. At baseline, at 6 weeks, and in the treatment arm at 12 weeks.
Secondary Change in blood pressure from baseline to 6 weeks The investigators will measure seated blood pressure in triplicate and use the average of the latter two readings for blood pressure (taken at baseline and 6 week visits). At baseline and at 6 weeks
Secondary Change in heart rate from baseline to 6 weeks The investigators will measure seated heart rate in triplicate and use the average of the latter two readings for heart rate(taken at baseline and 6 week visits). At baseline and at 6 weeks
Secondary Change in Quality of life at baseline and 6 weeks The investigators will measure this using the Duke Health Profile, another validated questionnaire to measure quality of life. At baseline, at 6 weeks, and in the treatment arm at 12 weeks.
See also
  Status Clinical Trial Phase
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT05963542 - Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia N/A
Completed NCT06339853 - Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia N/A
Recruiting NCT04069247 - Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia N/A
Completed NCT04493593 - Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility N/A
Recruiting NCT06278077 - Neurexan - a Clinical Trial in Short-Term Insomnia Patients Phase 2
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT04661306 - The Better Sleep for Supporters With Insomnia Study N/A
Recruiting NCT06207279 - Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
Recruiting NCT06006299 - Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC) N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Completed NCT04564807 - Testing an Online Insomnia Intervention N/A
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT04035200 - Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation Phase 2
Active, not recruiting NCT05027438 - Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention N/A
Recruiting NCT06053840 - An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia Phase 4
Not yet recruiting NCT06348082 - Project Women's Insomnia Sleep Health Equity Study (WISHES) N/A
Not yet recruiting NCT06363799 - Osteopathic Protocol for Insomnia in College Students N/A
Not yet recruiting NCT06025968 - Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis N/A
Not yet recruiting NCT05991492 - Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application N/A